Association between Stimulation-Site Pain and Clinical Improvement during Repetitive Transcranial Magnetic Stimulation for Patients with Major Depressive Disorders: A Prospective Observational Study at Two Sites
Neuropsychobiology · 2024
DOI: 10.1159/000538971 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Neuropsychobiology, 2024. Verfasst von Daisuke Hayashi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Major Depressive Disorder. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Introduction
The clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression (TRD) in Japan has not been adequately investigated. Furthermore, the relationship between stimulation-site pain and the antidepressant effects of rTMS has not been thoroughly examined. Therefore, this study aimed to clarify (1) the real-world efficacy and safety of rTMS for TRD in Japan and (2) the relationship between stimulation-site pain and clinical improvement of depressive symptoms.
Methods
We conducted a retrospective observational study involving 50 right-handed patients with TRD. All patients received high-frequency rTMS for up to 6 weeks. Depressive symptoms were assessed using the Montgomery-Åsberg depression rating scale (MADRS). Pain at the stimulation site was reported by the patients using a visual analog scale (VAS) after each session. Remission and response rates at 3 and 6 weeks were calculated based on the MADRS scores. The correlation between changes in the MADRS and VAS scores was examined.
Results
Remission and response rates were 36% and 46%, respectively, at the end of 3 weeks, and 60% and 70%, respectively, at 6 weeks. At the end of the treatment, there was significant correlation between the reduction of MADRS and VAS scores (r = 0.42, p = 0.003).
Conclusion
This study demonstrates the clinical efficacy of rTMS in Japan and the correlation between its antidepressant effects and stimulation-site pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
- Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Zitieren
APA
Hayashi, D., Yamazaki, R., Matsuda, Y., Igarashi, S., Taruishi, N., Kodaka, F., Shigeta, M., & Kito, S. (2024). Association between Stimulation-Site Pain and Clinical Improvement during Repetitive Transcranial Magnetic Stimulation for Patients with Major Depressive Disorders: A Prospective Observational Study at Two Sites. Neuropsychobiology. https://doi.org/10.1159/000538971
Vancouver
Hayashi D, Yamazaki R, Matsuda Y, Igarashi S, Taruishi N, Kodaka F, et al. Association between Stimulation-Site Pain and Clinical Improvement during Repetitive Transcranial Magnetic Stimulation for Patients with Major Depressive Disorders: A Prospective Observational Study at Two Sites. Neuropsychobiology. 2024. doi:10.1159/000538971
BibTeX
@article{Hayashi2024,
author = {Hayashi, Daisuke and Yamazaki, Ryuichi and Matsuda, Yuki and Igarashi, Shun and Taruishi, Nanase and Kodaka, Fumitoshi and Shigeta, Masahiro and Kito, Shinsuke},
title = {Association between Stimulation-Site Pain and Clinical Improvement during Repetitive Transcranial Magnetic Stimulation for Patients with Major Depressive Disorders: A Prospective Observational Study at Two Sites},
journal = {Neuropsychobiology},
year = {2024},
doi = {10.1159/000538971}
}
EUVIMED